Home Markets Global Pancreatitis Pipeline And Therapeutics Development 2017

Global Pancreatitis Pipeline And Therapeutics Development 2017

83
SHARE

Pancreatitis Pipeline provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 1, 13, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 1 molecules, respectively.

Get this research report at https://www.marketinsightsreports.com/reports/041311734/pancreatitis-pipeline-and-therapeutics-development-h1-2017

Comapnies discussed in this research are Astellas Pharma Inc, Boryung Pharmaceutical Co Ltd, ChoDang Pharm Co Ltd, Daewoong Pharmaceutical Co Ltd, Kukje Pharmaceutical Industry Co Ltd, RaQualia Pharma Inc and XuanZhu Pharma Co Ltd.

Drug Profiles mentioned are (lafutidine + irsogladine maleate), anaprazole sodium, ASP-6537, BGC-001, cholesteryl glucoside, DWJ-1386, DWJ-206, DWP-14012, KJ-14001, Small Molecules for Pancreatitis and tegoprazan.

Pancreatitis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Inquire more on this research at https://www.marketinsightsreports.com/reports/041311734/pancreatitis-pipeline-and-therapeutics-development-h1-2017/inquiry

Scope of this research covers the pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatitis (Gastrointestinal). The pipeline guide reviews pipeline therapeutics for Pancreatitis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Pancreatitis (Gastrointestinal) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Pancreatitis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatitis (Gastrointestinal).

List of Tables

  • Number of Products under Development for Pancreatitis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Stage and Target, H1 2017
  • Number of Products by Stage and Mechanism of Action, H1 2017
  • Number of Products by Stage and Route of Administration, H1 2017
  • Number of Products by Stage and Molecule Type, H1 2017
  • Pancreatitis – Pipeline by Angion Biomedica Corp, H1 2017
  • Pancreatitis – Pipeline by Atox Bio Ltd, H1 2017
  • Pancreatitis – Pipeline by Bharat Serums And Vaccines Ltd, H1 2017
  • Pancreatitis – Pipeline by CalciMedica Inc, H1 2017
  • Pancreatitis – Pipeline by Cypralis Ltd, H1 2017
  • Pancreatitis – Pipeline by Dynavax Technologies Corp, H1 2017
  • Pancreatitis – Pipeline by Generon (Shanghai) Corp Ltd, H1 2017
  • Pancreatitis – Pipeline by GlaxoSmithKline Plc, H1 2017
  • Pancreatitis – Pipeline by LipimetiX Development Inc, H1 2017
  • Pancreatitis – Pipeline by Novartis AG, H1 2017
  • Pancreatitis – Pipeline by Pharming Group NV, H1 2017
  • Pancreatitis – Pipeline by Sun BioPharma Inc, H1 2017
  • Pancreatitis – Dormant Projects, H1 2017
  • Pancreatitis – Discontinued Products, H1 2017 List of Figures
  • Number of Products under Development for Pancreatitis, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 2017
  • Number of Products by Stage and Routes of Administration, H1 2017
  • Number of Products by Molecule Types, H1 2017
  • Number of Products by Stage and Molecule Types, H1 2017

LEAVE A REPLY

Please enter your comment!
Please enter your name here